SCHEMBL13309082

SCHEMBL13309082

Bc1cnn2c(Nc3ccc(S(=O)(=O)O)cc3)cc(-c3ccccc3)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 6/20 0.46
▸ PKM P14618 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CLK1 P49759 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ TP53 P04637 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ TSHR P16473 1/20 0.44
▸ AHR P35869 1/20 0.42
▸ SNCA P37840 1/20 0.41
▸ CDK2 P24941 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13309399 0.90 MAPK1 (0.45) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13893805 0.89 GSK3B (0.48) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13309486 0.88 KDM4E (0.56) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13309050 0.88 ALDH1A1 (0.47) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13309179 0.87 GSK3B (0.48) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL11931057 0.87 GSK3B (0.61) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13309119 0.86 GSK3B (0.58) GSK3BKDM4EALDH1A1HPGDMEN1
SCHEMBL13308742 0.85 GSK3B (0.54) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL13309221 0.85 KDM4E (0.44) GSK3BPKMKDM4EALDH1A1HPGD
SCHEMBL14528871 0.85 KDM4E (0.43) GSK3BPKMKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934224-B1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORP (US) 2010-06-09 — — EP disclosed
EP-1534712-B1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORP (US) 2007-05-16 — — EP disclosed
Send feedback